Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Jean-Paul Kress
Barbara Krebs-Pohl
Lucinda Crabtree
Tim Demuth
Charlotte Lohmann
Board:
Marc Cluzel
Andrew Cheng
George Golumbeski
Krisja Vermeylen
Michael Brosnan
Sharon Curran
Shareholding in %:
Adage Capital Management LP 5.01
Armistice Capital LLC 4.69
Caligan Partners LP 2.81
DWS Investment GmbH 2.3
Goldman Sachs & Co. LLC (Private Banking) 10.98
Kynam Capital Management LP 10.61
Norges Bank Investment Management 2.81
Novartis AG 11.56
RP Management LLC (Investment Management) 3.55
The Vanguard Group, Inc. 2.61
Freefloat 43.08
Address: Semmelweisstrasse 7, 82152 Planegg
T: +49-89-89927-0
F: +49-89-89927-222
I: http://www.morphosys.de
E: info@morphosys.com